Contents
How long is the wait for PIP 2022?
The latest figures from the Department for Work and Pensions (DWP) show that at the end of October 2022, claims for Personal Independence Payment (PIP) were taking 16 weeks to process from point of registration to the decision being made. The statistics also indicate that it is taking 11 weeks from the time of the assessment provider’s referral to the decision being made.
- While waiting four months for a new claim to be processed may seem like a long time, it has actually come down from 24 weeks for the end-to-end journey recorded in October 2021.
- Similarly, the 11-week wait from assessment to decision is a reduction of five weeks from the 16 weeks recorded in 2021.
- In November 2022, DWP said that reducing customer journey times for PIP claimants is a “priority for the department and we are working constantly to make improvements to our service”.
While an 16-week wait may provide little comfort for anyone considering making a new claim for the benefit – or those already midway through the journey – it’s worth keeping in mind that successful claims are backdated to the point of application. A successful claim for PIP is worth between £24.45 and £156.90 each week.
As the benefit is paid every four weeks, this means people with a long-term illness, disability, mental or physical health condition could receive regular payments of between £97.80 and £627.60. DWP shared its plans after former SNP MP, Margaret Ferrier, asked what steps are being taken to reduce PIP delays and waiting times.
In a written response in November, Minister or Disabled People, Tom Pursglove, said: “We are committed to ensuring people can access financial support through Personal Independence Payment (PIP) in a timely manner, taking into account the need to review all available evidence.
Using a blend of phone, video and face-to-face assessments to support customers and deliver a more efficient and user-centred service Increasing case manager and assessment provider health professional resources Prioritising new claims, while safeguarding claimants awaiting award reviews, who have returned their information as required, to ensure their payments continue until their review can be completed
The latest statistics from the DWP show that by the end of October, there were more than three million people across the country claiming PIP. The regional breakdown includes nearly 330,000 claimants living in Scotland, 2.6 million in England and 226,000 in Wales.
How long does it take to get a decision from assessment to PIP?
How long do you have to wait to hear the results of your PIP assessment? – Once complete, your assessment will be sent to the DWP who will make a final decision. As of April 2023, it takes 13 weeks ‘end to end’ from registration to decision. The most recent data shows that the average waiting time between assessment and decision is nine weeks, though this may vary.
How long does it take to get your first PIP payment?
If you want to apply by post – It’s quicker to apply by phone, but if that isn’t possible you can write to the DWP and ask for a PIP1 form. Write to the PIP New Claims address. You’ll need to tell them why you (or someone else) can’t fill in the PIP1 form over the phone.
- Personal Independence Payment New Claims Post Handling Site B Wolverhampton WV99 1AH When you get the PIP1 form, fill it in and send it to the address on the form as soon as possible.
- You must send it back within 1 month after the DWP got your letter – that might be a few days before you get the form.
If the DWP decide you can get PIP, they’ll pay you the money you should have got from the date they received the PIP1 form.
Are PIP reviews being delayed?
As the DWP grapples with personal independence payment (PIP) reassessment delays, Carri Swann considers how to advise affected claimants. Background As of October 2022, it takes the DWP 16 weeks to decide a new PIP claim. While nowhere near the August 2021 peak of 26 weeks, 16 weeks is still a long time for new claimants to wait.1 DWP, Personal Independence Payment: official statistics to October 2022, available at gov.uk, (‘PIP Official Statistics’), para 6 The DWP is taking steps to ‘manage’ these delays, like increasing its numbers of case managers and subcontracted healthcare professionals.2 DWP email to stakeholders, 16 November 2022 It is also prioritising new claimants for assessment ahead of existing claimants whose cases have come up for review.
- Unfortunately, this measure is shifting delays from one part of the PIP system – new claims – to another – the award review process.
- Delays when you have an existing award The DWP does not publish statistics on how long a PIP reassessment takes, but CPAG’s Early Warning System has heard about claimants waiting a year or more between completing a review form and getting a new entitlement decision.
Sometimes these claimants have been sent a review form as part of a planned award review, and sometimes because they have notified the DWP of a deterioration in their health. These delays present a few different issues. In this article, two are considered.
- First, there is the fear that a fixed-term PIP award might end before a new award is made.
- Second, there is the issue that people wait too long for a much-needed PIP increase after a deterioration in their health, and when it comes, it is not always applied from the date they expect.1.
- Automatic extensions The DWP has taken steps to prevent PIP from going out of payment due to reassessment delays by introducing automatic extensions for some awards.
If, 35 days before an award is due to end, it is still ‘awaiting review’, it will be automatically extended by up to 12 months.3 Confirmed in DWP, LA Welfare Direct 9/2022, paras 28-31, available at gov.uk Automatic extensions are not new, having been used extensively at the height of the pandemic.
However, the latest policy offers the longest extensions to date. It also promises written confirmation, which has not always been available in the past. Does the automatic extensions policy apply to all PIP awards? The policy only appears to apply when an award is subject to review, This is not a statutory term.
Being subject to review means that a claimant is sent an award review form (AR1) to complete before their fixed-term PIP award is due to end. The DWP then reassesses them and makes a new decision on their entitlement without them having to reclaim PIP.
- Some PIP awards of two years or less are not ‘subject to review’.4 para P2063 ADM; DWP response to FOI request FOI2021/ 13215, 2 March 2021, available at ; there is implicit confirmation that this approach continues in the PIP Official Statistics at para 4.
- A decision maker has discretion to make this kind of award if they think that (eg, because of planned treatment) the claimant will no longer qualify for PIP at the end of the award period.
The DWP sometimes calls these ‘short-term awards without review’. The DWP makes lots of short-term PIP awards: as of October 2022, 77 per cent of new awards were for two years or less.5 PIP Official Statistics, para 4 As a result, it is likely that many PIP claimants are not subject to review.
- Instead of being sent an award review form, short-term award claimants get a letter some months before their PIP is due to end prompting them to make a new PIP claim.
- This ‘renewal claim’ is made in the same way as any other new claim and can be put in up to six months before the existing award is due to end.6 Reg 33(2) Universal Credit, Personal Independence Payment, Jobseeker’s Allowance and Employment and Support Allowance (Claims and Payments) Regulations 2013, No.380.
As noted above, the average waiting time for a decision on new claims is 16 weeks. Although ‘review’ and ‘renewal’ are sometimes talked about interchangeably, in practice these are clearly two quite different processes. For a claimant coming towards the end of a fixed-term PIP award, it is crucial to know what they are expected to do and when.
If you are not sure whether your client is subject to review or not, you can normally find this information in their award letter or by calling the PIP helpline.7 The wording in the award letter might be: ‘We will also contact you while you are getting PIP to see if your needs have changed and to look at the amount you get.
This will be after,’ If your client’s award is subject to review, and this has not been completed 35 days before its end date, the award should be automatically extended as described above. If it is not subject to review, it appears that it will not be extended.
This could mean your client’s award ending before their renewal claim is decided, leaving a gap in payments. What is not clear is whether your client could get around this by making a supersession request (ie, reporting a change of circumstances) more than 35 days before their existing award ends. If they do so, they are classed as awaiting an unplanned rather than a planned review.
The policy and indeed the relevant law does not distinguish between the two, and it is possible that having either kind of review outstanding will mean their award is identified for extension. When you are advising someone who has a short-term award without review, you might therefore suggest they report a change of circumstances at the same time as making a renewal claim.
A relevant change of circumstances can be that their difficulties are expected to last beyond the end date of their award, even if the level of their difficulties has not changed.8 PH v SSWP (DLA) UKUT 268 (AAC). While this was a DLA case, it is strongly arguable that the reasoning also applies to fixed-term awards of PIP.
This approach, although admin-heavy, might give them the best chance of being protected from a gap in payments. The best advice will always depend on the facts of the case. Can an award made by the tribunal be automatically extended? Yes, in principle.
A PIP award made by the tribunal can be superseded for a change of circumstances in the same way as other awards.9 Reg 23(1)(a) Universal Credit, Personal Independence Payment, Jobseeker’s Allowance and Employment and Support Allowance (Decisions and Appeals) Regulations 2013, No.381 (‘UC,PIP,JSA&ESA(D&A) Regs’) If this is the legal ground the DWP is using to make automatic extensions – and it appears to be – then it follows that an award made by the tribunal will be automatically extended, so long as it is ‘awaiting review’.
However, some advisers have reported that the DWP is not always attaching review dates to tribunal awards in the way as it does to other awards – ie, even where they are for more than two years. These awards are therefore not being automatically extended.
The DWP does not have any statutory obligation to review awards, but its approach here does not appear to be in line with its own policies.10 See footnote 4 When you are advising someone who has an award made by the tribunal, do check their DWP award letter or call the PIP helpline to ask if an award review date has been set.
The answer will determine the advice you give (see answer to ‘ Does the automatic extensions policy apply to all PIP awards? ‘ above). How can my client prove their extended PIP entitlement – eg, for a blue badge application? As of mid-December, affected claimants are automatically sent letters confirming their extended PIP entitlement.
The DWP has told stakeholders that any affected claimant who has not automatically received a letter (eg, because their award was extended before December) can call the PIP helpline and ask for one. CPAG’s Early Warning System has heard that some councils are adapting to the situation by offering longer Blue Badge extensions based on previous medical information in appropriate cases, rather than extending for 12 months or less in line with the PIP award.2.
Deterioration in health and effective date of supersession A second issue for existing PIP claimants hit by assessment delays is that they may wait a long time for much-needed PIP increases after experiencing a deterioration in their health. When they do get a new decision, the increase does not always apply from the date they expect.
From what date should PIP increase? There are several factors to consider. The required period condition PIP can usually increase no earlier than three months after your client starts satisfying the conditions for a higher rate. This is part of the ‘required period’ condition for PIP eligibility, and is statutory.
So if, for example, your client’s needs increased in December 2022, their award can increase from no earlier than March 2023. They should still report the change as soon as possible, and not wait three months to do so, as this will simply hold up the reassessment process.
The supersession rules The date of any increase will also depend on which grounds of supersession are being used by the DWP to increase your client’s award. The answer to this question determines the relevant date of the increase – but it is not always straightforward. (a) If your client actively contacted the DWP to report a change in circumstances In this situation, you client’s award should be superseded on the grounds of a change of circumstances.11 Regs 12 and 13 Social Security (Personal Independence Payment) Regulations 2013, No.377; reg 23(1)(a) and Sch 1 para 15 UC,PIP,JSA&ESA(D&A) Regs If they report the change ‘no later than one month’ after it happens (or later if the DWP agrees), then the supersession takes effect from the date of the change of circumstances.
This needs to be read together with the required period rules above – ie, so that, technically, the change would need to be reported within a month of satisfying the required period condition. In practice however, it remains good advice not to wait until then, but simply to report the change (the deterioration in health) as soon as possible.
For example, if your client’s mobility gets worse because of an accident on 1 December 2022, and they notify the change in their needs any time between 1 December 2022 and 1 April 2023, their award should be increased from 1 March 2023. If they tell the DWP about the change on a date after 1 April 2023, then unless the DWP agrees to allow a late notification, the increase will only take effect from that notification date.
(b) If your client instead completed an award review form that the DWP sent them unprompted as part of a planned award review In this case, you could argue that your client notified the DWP of a change of circumstances on the date it received their completed AR1 form; that the DWP should therefore supersede their award on the grounds of a change of circumstances; and that the effective date of any increase should be worked out accordingly.12 See footnote 11.
- Note that, for Sch 1 para 18 of the UC,PIP,JSA&ESA(D&A) Regs, it seems unlikely that the DWP sending you an AR1 in a planned review case could amount to ‘action with a view to supersession’.
- However, the success of this approach might be dependent on what your client wrote in their AR1 form.
- The DWP may not agree to supersede on this basis, and want instead to apply the alternative rule described below.
The alternative ground of supersession In either (a) or (b), the DWP might try to supersede your client’s award on the alternative grounds of receipt of new medical evidence from a healthcare professional.13 s10(5) Social Security Act 1998; reg 26 UC,PIP,JSA&ESA(D&A) Regs Supersessions made on this ground have a different effective date from supersessions made for a change of circumstances.
If this medical evidence ground applies, any increase in your client’s award will only apply from the date of the DWP’s new decision. When both possible grounds for a supersession apply, and the DWP uses the ground that is less generous to the claimant, that is at least potentially wrong, and its decision can be challenged.
In the reported decision in DS v SSWP (PIP) UKUT 538 (AAC), reported as AACR 19, Judge Mesher noted that the PIP supersession rules make particular provisions about changes of circumstance that are advantageous to the claimant, and stated: ‘So far as decisions that are advantageous to the claimant go, there is then no difficulty in applying a general principle that the claimant should be able to take the benefit of whatever ground gives the most advantage.’
How long does fast track PIP take?
If you are terminally ill, you can apply for PIP using a fast-track process called special rules. You can apply if your doctor thinks you may be reasonably expected to live for less than 12 months. You should get your first payment within 2 weeks of applying.
What day is PIP usually paid?
THOUSANDS of people on Personal Independence Payment (PIP) can expect to see money land in their accounts over summer. The tax-free money usually hits bank accounts every four weeks, so here’s when you can expect it. 
1 Some households on PIP can expect earlier payments over the coming weeks Credit: Alamy PIP is designed to help with extra living costs if you have a long-term mental or physical health condition or disability, There are two parts to the benefit which means you can get paid different amounts depending on your circumstances.
How long should I wait to hear about my PIP claim?
Getting a Personal Independence Payment (PIP) decision – The Department for Work and Pensions (DWP) will make a decision on your Personal Independence Payment (PIP) claim after the medical assessment has been completed. The DWP’s decision about your PIP entitlement is based on the information in:
Your claim form The documents you sent with your claim form The health professional’s notes from the medical assessment.
On average, it takes the DWP 20 weeks from the date you started your claim to make a decision. Some claims take less time; some take more.
How many PIP claims are successful?
Success rates for PIP claims by condition The DWP record every successful PIP claim under one of over 500 different health conditions, depending on which one they think is your main source of points. The table below shows what percentage of claims for each condition are successful For comparison, the overall average success rate for PIP claims is 52%.
| Cardiovascular disease – Other / type not known | 49.60% |
| Abdomen – Injuries/Fracture/Dislocation Of | 55.00% |
| Achondroplasia | 86.10% |
| Acne Vulgaris | 19.70% |
| Addison’s Disease | 48.70% |
| Adhd / Add | 49.70% |
| Adhesive Capsulitis (Frozen Shoulder) | 39.50% |
| Adrenal Diseases – Other / Type Not Known | 43.80% |
| Agoraphobia | 65.20% |
| Alcohol Misuse | 61.60% |
| Allergy No Risk Of Anaphylaxis | 20.30% |
| Allergy Risk Of Anaphylaxis Unknown Or Not Fully Assessed | 27.50% |
| Allergy With A Risk Of Anaphylaxis | 26.50% |
| Amblyopia | 59.20% |
| Amino Acid Metabolism – Disorders Of | 37.10% |
| Amputation – Lower Limb(S) | 88.50% |
| Amputation – Upper Limb(S) | 76.70% |
| Amputations – Upper & Lower Limb/S | 91.30% |
| Amyloidosis | 82.10% |
| Anaemia – Aplastic | 59.40% |
| Anaemia – B12 (Pernicious)/Folate Deficiency | 35.10% |
| Anaemia – Iron Deficiency | 33.50% |
| Anaemia – Sickle Cell | 48.60% |
| Anaemias – Other / Type Not Known | 42.00% |
| Aneurysm – Aortic | 60.40% |
| Aneurysm – Cerebral | 64.30% |
| Aneurysms – Other / Type Not Known | 55.10% |
| Angina | 55.60% |
| Angioedema | 39.80% |
| Angiosarcoma | 90.80% |
| Ankle And Foot Disorders – Other / Type Not Known | 45.10% |
| Ankylosing Spondylitis | 70.20% |
| Anorectal Abscess | 37.30% |
| Anorexia Nervosa | 71.20% |
| Anterior Uveitis (Iritis) | 60.50% |
| Antiphospholipid Syndrome | 61.70% |
| Anxiety Disorders – Other / Type Not Known | 38.60% |
| Aortic Valve Disease | 47.80% |
| Arterial Disease Excluding Coronary – Other / Type Not Known | 57.90% |
| Arthritis – Psoriatic | 69.30% |
| Arthritis – Reactive | 68.60% |
| Asbestosis | 74.60% |
| Ascites | 76.90% |
| Asperger Syndrome | 51.10% |
| Asthma | 48.90% |
| Astigmatism | 51.50% |
| Ataxia – Friedrich’s | 92.50% |
| Ataxias – Other / Type Not Known | 81.50% |
| Atherosclerosis (Pvd / Claudication) | 64.40% |
| Atrial Fibrillation/Flutter | 49.20% |
| Atrioseptal Defect (ASD) | 56.90% |
| Attention To Artificial Opening Colostomy/Ileostomy/ Stoma – No Underlying Diagnosis | 38.40% |
| Autism | 72.30% |
| Autoimmune (Idiopathic) Thrombocytopaenic Purpura (ITP) | 42.90% |
| Autoimmune Disease – Other / Type Not Known | 60.70% |
| Autoimmune Hepatitis | 45.50% |
| Back Pain – Non Specific (Mechanical) | 56.20% |
| Back Pain – Specific – Other / Type Not Known | 68.80% |
| Bacterial Diseases – Other / Type Not Known | 55.20% |
| Bedwetting (Enuresis) | 33.30% |
| Behcet’s Disease | 58.00% |
| Bipolar Affective Disorder (Hypomania / Mania) | 61.30% |
| Bladder – Cancer Of | 76.50% |
| Bladder Urethra Testes And Penis – Other Diseases Of / Type Not Known | 28.00% |
| Blepharospasm | 62.20% |
| Blood Disorders – Type Not Known | 51.00% |
| Blood Vessels/Lymphatics – Other Diseases Of / Type Not Known | 57.30% |
| Body Dysmorphic Disorder (BDD) | 51.80% |
| Bone – Other Cancers Of / Type Not Known | 85.90% |
| Bowel (Colon Recturm Anus) – Cancer Of | 87.20% |
| Brachial Plexus | 76.10% |
| Bradycardia | 36.90% |
| Brain And Spinal Cord – Cancer Of | 91.30% |
| Breast – Cancer Of | 80.20% |
| Bronchiectasis | 65.10% |
| Bronchus – Cancer Of | 96.60% |
| Buerger’s Disease | 70.30% |
| Bulimia Nervosa | 57.00% |
| Bullous Disease – Other / Type Not Known | 40.10% |
| Burns | 61.30% |
| Bursitis | 50.20% |
| Cancers – Other / Type Not Known | 78.40% |
| Carbohydrate Metabolism – Disorders Of | 58.80% |
| Cardiac Arrhythmia – Pacemaker/Implantable Defibrillator Fitted | 52.10% |
| Cardiac Arrhythmias – Other / Type Not Known | 44.10% |
| Cardiac Failure | 66.10% |
| Cardiomyopathy | 56.30% |
| Cardiovascular Disease – Other / Type Not Known | 49.70% |
| Carpal Tunnel Syndrome | 45.90% |
| Cataplexy | 50.30% |
| Cataract | 58.00% |
| Cellulitis | 65.70% |
| Cerebral Palsy – Ataxic | 87.30% |
| Cerebral Palsy – Athetoid | 98.50% |
| Cerebral Palsy – Diplegic | 88.70% |
| Cerebral Palsy – Hemiplegic | 88.40% |
| Cerebral Palsy – Other / Type Not Known | 86.70% |
| Cerebral Palsy – Quadriplegic | 99.50% |
| Cerebrovascular Accident (Stroke) | 78.30% |
| Cerebrovascular Disease – Other / Type Not Known | 67.70% |
| Cervical Disc Lesion | 64.60% |
| Cervical Spondylosis | 65.90% |
| Cervix – Cancer Of | 84.30% |
| Charcot Marie Tooth Disease | 75.20% |
| Chondromalacia Patellae | 54.30% |
| Chondrosarcoma | 85.60% |
| Chorioretinal Disorders – Other / Type Not Known | 65.50% |
| Chromosomal Syndrome – Other Type / Not Known | 77.40% |
| Chronic Fatigue Syndrome (CFS) | 54.80% |
| Chronic Obstructive Pulmonary Disease (COPD) Chronic Bronchitis/Emphysema | 66.30% |
| Chronic Secretory Otitis Media | 28.00% |
| Chronic Suppurative Otitis Media | 35.20% |
| Cirrhosis – Alcohol Induced | 64.80% |
| Cirrhosis – Autoimmune | 54.50% |
| Cirrhosis – Other / Type Not Known | 60.70% |
| Cleft Lip | 52.60% |
| Cleft Lip With Cleft Palate | 34.20% |
| Clotting Disorders – Other / Type Not Known | 49.40% |
| Club Foot (Talipes) | 51.90% |
| Coarctation Of The Aorta | 48.10% |
| Coeliac Disease | 27.70% |
| Cognitive Disorder Due To Stroke | 88.60% |
| Cognitive Disorders – Other / Type Not Known | 80.10% |
| Collagen And Elastic Tissue – Other Diseases Of / Type Not Known | 48.00% |
| Colon – Other Diseases Of / Type Not Known | 40.10% |
| Compartment Syndrome (Volkmann’s Ischaemia) | 66.70% |
| Complications Of Prematurity | 73.20% |
| Conduct Disorder (Including Oppositional Defiant Disorder) | 58.30% |
| Conductive Hearing Loss – Other Causes Of / Type Not Known | 31.50% |
| Conductive Hearing Loss Due To Trauma | 31.70% |
| Conjunctiva Cornea Eyelids And Lacrimal Apparatus – Other Diseases Of / Type Not Known) | 54.80% |
| Constipation | 28.40% |
| Conversion Disorder (Hysteria) | 79.10% |
| Corneal Ulceration | 51.50% |
| Coronavirus COVID-19 | 47.00% |
| Cortical Blindness | 92.30% |
| Creutzfeldt – Jacob Disease (CJD) | 100.00% |
| Crohns Disease | 30.70% |
| Crystal Deposition Disorders – Other / Type Not Known | 48.40% |
| Cushing’s Syndrome | 60.00% |
| Cystic Fibrosis | 61.30% |
| Deafness – Congenital | 76.20% |
| Deep Vein Thrombosis | 51.30% |
| Degenerative Neuronal Diseases – Other / Type Not Known | 89.10% |
| Dementia | 94.10% |
| Depressive Disorder | 50.70% |
| Dermatitis Herpetiformis | 33.70% |
| Dermatomyositis | 73.80% |
| Diabetes Insipidus | 45.70% |
| Diabetes Mellitus (Category Unknown) | 45.60% |
| Diabetes Mellitus Type 1 (Insulin Dependent) | 28.20% |
| Diabetes Mellitus Type 2 (Non Insulin Dependent) | 45.80% |
| Diabetic Neuropathy | 73.40% |
| Diabetic Retinopathy | 77.80% |
| Diplopia (Double Vision) | 45.70% |
| Disease Affecting Hearing & Balance – Other/ Type Not Known | 44.60% |
| Dislocation Of The Hip – Congenital | 77.90% |
| Dissociative Disorders – Other / Type Not Known | 69.90% |
| Disturbances Of Consciousness – Non-Epileptic – Other / Type Not Known | 55.70% |
| Diverticular Disease / Diverticulitis | 33.70% |
| Dizziness – Cause Not Specified | 39.60% |
| Down’s Syndrome | 99.60% |
| Drop Attacks | 62.40% |
| Drug Misuse | 56.90% |
| Dupuytrens Contracture | 54.00% |
| Dyslexia | 22.30% |
| Dyspraxia | 45.50% |
| Dystrophia Myotonica | 76.90% |
| Eating Disorders Not Otherwise Specified (EDNOS) | 60.90% |
| Eczema – Varicose | 28.40% |
| Eczema (Dermatitis) | 20.40% |
| Ehlers Danlos Syndrome | 69.20% |
| Elbow Disorders – Other / Type Not Known | 42.60% |
| Empyema | 62.80% |
| Endocrine Diseases – Other / Type Not Known | 45.30% |
| Endometriosis | 34.50% |
| Endometrium (Uterus / Womb) – Cancer Of | 86.20% |
| Entropion | 50.00% |
| Epidemolysis Bullosa | 57.80% |
| Epiphyseal Dysplasia – Multiple | 78.50% |
| Essential Tremor – Benign | 66.00% |
| Ewing’s Sarcoma | 88.00% |
| Extrinsic Allergic Alveolitis | 84.20% |
| Eye Movement – Other Disorders Of / Type Not Known | 48.70% |
| Eyes – Injuries To | 36.40% |
| Facioscapulohumeral Dystrophy | 82.90% |
| Factitious Disorders – Other / Type Not Known | 52.00% |
| Faecal Soiling (Encopresis) | 23.80% |
| Failure To Thrive | 75.00% |
| Fallots Tetralogy | 44.30% |
| Fibroids | 26.30% |
| Fibromyalgia | 62.70% |
| Fibrosarcoma | 78.00% |
| Fibrosing Alveolitis | 79.50% |
| Fistula In Anus | 32.10% |
| Food Intolerance | 21.00% |
| Fore Foot Pain (Metatarsalgia) | 44.30% |
| Fracture Complications – Other / Type Not Known | 66.60% |
| Fragile X Syndrome | 91.90% |
| Gallbladder And Biliary Tract – Other Diseases Of / Type Not Known | 45.10% |
| Gallstones | 34.30% |
| Gastrointestinal Tract – Other Cancers Of / Type Not Known | 90.70% |
| Gastrointestinal Tract – Other Diseases Of / Type Not Known | 40.40% |
| Generalised Anxiety Disorder | 42.70% |
| Generalised Musculoskeletal Disease – Other / Type Not Known | 62.30% |
| Generalised Seizures (With Status Epilepticus In Last 12 Months) | 58.70% |
| Generalised Seizures (Without Status Epilepticus In Last 12 Months) | 50.10% |
| Genetic Disorders Dysplasias And Malformations – Other / Type Not Known | 71.90% |
| Genitourinary Disease – Other / Type Not Known | 36.20% |
| Genitourinary Tract – Other Cancers Of / Type Not Known | 84.60% |
| Giant Cell Tumour – Malignant | 78.00% |
| Glaucoma | 63.10% |
| Glomerulonephritis | 55.40% |
| Glucose 6 Phosphate Dehydrogenase (G6PD) Deficiency | 52.90% |
| Goitre | 26.50% |
| Golfers Elbow (Medial Epicondylitis) | 38.30% |
| Gout | 45.40% |
| Granulomatous Lung Disease And Pulmonary Infiltration – Other / Type Not Known | 68.80% |
| Growth Hormone Deficiency | 54.10% |
| Guillain Barre Syndrome | 80.50% |
| Haematological System – Other Cancers Of / Type Not Known | 81.90% |
| Haemochromatosis | 51.20% |
| Haemolytic Disorders – Other / Type Not Known | 54.10% |
| Haemophilia A | 57.80% |
| Haemophilia B (Christmas Disease) | 64.30% |
| Haemorrhoids | 21.10% |
| Hallux Valgus /Rigidus | 39.70% |
| Head Injury – Cognitive And Sensorimotor Impairment | 78.70% |
| Head Injury – Cognitive Impairment | 74.10% |
| Head Injury – Sensorimotor Impairment | 70.60% |
| Headache – Other Causes Of / Cause Not Known | 30.20% |
| Hearing Loss – Mixed | 41.30% |
| Heart And Lung Transplantation | 76.90% |
| Heart Block | 52.10% |
| Heart Disease – Congenital – Other / Type Not Known | 53.40% |
| Heart Transplantation | 66.50% |
| Hemianopia | 62.20% |
| Hepatic Encephalopathy | 76.80% |
| Hepatitis – Chronic – Other / Type Not Known | 51.40% |
| Hepatitis B And D Infection | 33.80% |
| Hepatitis C Infection | 53.20% |
| Hereditary Multiple Exostosis (Diaphyseal Aclasis) | 68.50% |
| Hereditary Spherocytosis | 43.10% |
| Hernia | 44.80% |
| Herpes Zoster – Ophthalmic | 44.80% |
| Hiatus Hernia / Gastroesophageal Reflux Disease / Reflux Oesophagitis | 33.70% |
| Hip Disorders – Other / Type Not Known | 67.40% |
| Hirschprung Disease | 31.60% |
| HIV/Aids | 48.60% |
| Hodgkins Lymphoma | 78.40% |
| Huntington’s Disease | 85.00% |
| Hydrocephalus | 65.40% |
| Hydronephrosis | 39.40% |
| Hyperlipidaemia | 55.40% |
| Hypermetropia (Long-Sighted) | 48.10% |
| Hypermobility Syndrome | 53.40% |
| Hyperparathyroidism | 36.90% |
| Hypersensitivity Diseases – Other / Type Not Known | 36.80% |
| Hypertension | 47.10% |
| Hypertensive Retinopathy | 54.70% |
| Hyperthyroidism (Thyrotoxicosis) Including Graves Disease | 32.40% |
| Hypoparathyroidism | 36.80% |
| Hypothalamic And Pituitary Diseases – Other / Type Not Known | 43.40% |
| Hypothyroidism (Myxoedema) | 34.70% |
| Immune System – Other Diseases Of / Type Not Known | 51.70% |
| Inborn Errors Of Metabolism – Other / Type Not Known | 53.40% |
| Incontinence – Stress | 15.70% |
| Incontinence – Urge | 13.70% |
| Incontinence (Not Enuresis/Bed Wetting) – Other / Type Not Known | 20.60% |
| Infections – Other | 72.30% |
| Infections – Other / Type Not Known | 46.30% |
| Infectious Diseases – Other / Type Not Known | 59.60% |
| Inflammatory Arthritis – Other / Type Not Known | 67.10% |
| Interstitial Nephritis | 56.40% |
| Irritable Bowel Syndrome (IBS) | 26.10% |
| Ischaemic Heart Disease – Other / Type Not Known | 56.90% |
| Juvenile Chronic Arthritis (Still’s Disease) | 69.20% |
| Keratitis | 46.50% |
| Keratoconus | 50.50% |
| Kidney – Cancer Of | 88.80% |
| Kidney Disease – Other / Type Not Known | 53.60% |
| Knee Disorders – Other / Type Not Known | 52.50% |
| Kyphosis | 68.50% |
| Labyrinthitis | 34.90% |
| Larynx – Cancer Of | 83.70% |
| Learning Disability – Other / Type Not Known | 89.40% |
| Leg Ulcers (Arterial) | 68.10% |
| Leg Ulcers (Venous) | 65.80% |
| Leukaemia – Lymphoblastic – Acute | 85.50% |
| Leukaemia – Lymphocytic – Chronic | 67.20% |
| Leukaemia – Myelogenous (Myeloid) Acute | 89.20% |
| Leukaemia – Myeloid – Chronic | 71.40% |
| Leukaemias – Other / Type Not Known | 73.40% |
| Ligamentous Instability Of Knee | 53.00% |
| Liver – Cancer Of | 93.30% |
| Liver Failure – Features Of – Other / Features Not Known | 68.40% |
| Liver Transplantation | 57.90% |
| Lower Limb – Injuries/Fracture/Dislocation Of | 55.60% |
| Lower Respiratory Tract – Other Diseases Of / Type Not Known | 59.40% |
| Lumbar Disc Lesion | 74.90% |
| Lumbar Spondylosis (OA Spine) | 75.70% |
| Lung Cancers – Other | 96.00% |
| Lung Transplantation | 82.00% |
| Lymphoedema | 71.60% |
| Macular Degeneration | 78.60% |
| Malaria | 61.50% |
| Malformations Of The Heart – Congenital – Other / Type Not Known | 50.00% |
| Marfan’s Syndrome | 62.40% |
| Mastoiditis | 25.90% |
| Melanoma | 86.60% |
| Menieres Disease | 41.90% |
| Meniscal Lesions | 50.20% |
| Mesothelioma | 98.90% |
| Metabolic Diseases – Other / Type Not Known | 53.10% |
| Metabolic Red Cell Disorders – Other / Type Not Known | 61.30% |
| Migraine | 26.70% |
| Mitral Valve | 49.90% |
| Mood Disorders – Other / Type Not Known | 51.60% |
| Motor Neurone Disease | 97.50% |
| Mouth/Tongue – Cancer Of | 84.30% |
| Movement Disorders – Other / Type Not Known | 74.00% |
| Multiple – Injuries/Fracture/Dislocation | 69.20% |
| Multiple Sclerosis | 78.90% |
| Munchausen Syndrome | 57.10% |
| Muscle – Other Diseases Of / Type Not Known | 74.40% |
| Muscular Dystrophy – Becker Type | 82.60% |
| Muscular Dystrophy – Duchenne | 97.00% |
| Muscular Dystrophy – Limb Girdle | 88.40% |
| Muscular Dystrophy – Other / Type Not Known | 84.10% |
| Musculoskeletal Disease – Regional / Localised – Other / Type Not Known | 56.00% |
| Myasthenia Gravis | 66.50% |
| Myeloma | 88.20% |
| Myocardial Infarction | 48.70% |
| Myopia (Short-Sighted) | 57.70% |
| Narcolepsy | 47.40% |
| Neck Disorders – Other / Type Not Known | 52.00% |
| Nephrotic Syndrome | 52.30% |
| Neuroblastoma | 76.80% |
| Neurofibromatosis | 61.10% |
| Neurological Disorders – Other / Type Not Known | 66.20% |
| Neuropathies – Other / Type Not Known Including Peripheral | 63.30% |
| Non Epileptic Attack Disorder (Pseudoseizures) | 59.20% |
| Non Hodgkins Lymphoma | 80.40% |
| Nystagmus | 65.80% |
| Obesity | 78.10% |
| Obsessive Compulsive Disorder (OCD) | 54.30% |
| Oesophageal Varices | 48.10% |
| Oesophagus – Cancer Of | 93.60% |
| Oesophagus Stomach And Duodenum – Other Diseases Of / Type Not Known | 41.90% |
| Old Age | 83.60% |
| Optic Atrophy | 84.40% |
| Optic Neuritis | 66.40% |
| Oral Allergy Syndrome | 11.60% |
| Orbital Cellulitis | 23.80% |
| Osgood Schlatters Disease | 41.50% |
| Osteoarthritis Of Hip | 73.80% |
| Osteoarthritis Of Knee | 64.20% |
| Osteoarthritis Of Other Single Joint | 56.50% |
| Osteochondritis | 69.00% |
| Osteochondritis Dissecans | 61.70% |
| Osteogenesis Imperfecta | 74.10% |
| Osteomalacia | 72.30% |
| Osteonecrosis | 74.70% |
| Osteoporosis | 67.60% |
| Osteosarcoma | 85.30% |
| Other Metabolic And Endocrine Disorders Of Musculoskeletal System | 61.80% |
| Otitis Externa – Chronic | 30.80% |
| Otosclerosis | 34.40% |
| Ovarian Cyst (Benign) | 39.70% |
| Ovary – Cancer Of | 91.10% |
| Ovary Uterus Cervix Vagina And Vulva – Other Diseases Of / Type Not Known | 37.60% |
| Paget’s Disease | 75.30% |
| Pain Syndromes – Chronic – Other / Type Not Known | 64.80% |
| Pancreas – Cancer Of | 96.70% |
| Pancreas – Other Diseases Of / Type Not Known | 51.00% |
| Pancreatitis – Chronic | 53.40% |
| Panic Disorder | 46.10% |
| Papulosquamous And Inflammatory Rashes – Other / Type Not Known | 31.90% |
| Paraplegia (Traumatic) | 97.80% |
| Parathyroid Diseases – Other / Type Not Known | 39.20% |
| Parkinson’s Disease | 83.10% |
| Parkinson’s Syndrome / Parkinsonism | 86.40% |
| Partial Seizures (With Status Epilepticus In Last 12 Months) | 47.60% |
| Partial Seizures (Without Status Epilepticus In Last 12 Months) | 40.20% |
| Patellar Dislocation – Recurrent | 58.70% |
| Patent Ductus Arteriosus (PDA) | 46.80% |
| Pelvic Inflammatory Disease (PID) | 41.40% |
| Pelvis – Injuries/Fracture/Dislocation Of | 67.90% |
| Pemphigoid | 36.60% |
| Pemphigus Vulgaris | 39.10% |
| Peptic Ulcer (Gastric And Duodenal)/Gastritis | 38.80% |
| Pericarditis | 40.80% |
| Peripheral Nerve Injury – Other / Type Not Known | 60.00% |
| Peripheral Venous Disease – Other / Type Not Known | 59.10% |
| Peritonitis | 71.70% |
| Personality Disorder | 61.80% |
| Perthes Disease | 67.20% |
| Phobia – Social | 44.70% |
| Phobia – Specific | 45.60% |
| Platelet Disorders – Other / Type Not Known | 43.60% |
| Pleura – Other Diseases Of / Type Not Known | 58.10% |
| Pleural Effusion | 60.90% |
| Pneumoconiosis – Coalworkers | 91.70% |
| Pneumoconiosis – Other / Type Not Known | 71.30% |
| Pneumonia | 60.30% |
| Pneumothorax | 38.20% |
| Poliomyelitis And Post Polio Syndrome | 86.20% |
| Polyarteritis Nodosa | 73.70% |
| Polycythaemia | 52.20% |
| Polymyalgia Rheumatica | 67.20% |
| Polymyositis | 80.90% |
| Porphyria | 60.60% |
| Post Traumatic Stress Disorder (PTSD) | 58.20% |
| Posterior (Choroiditis) | 73.50% |
| Posterior Vitreous Detachment | 41.50% |
| Presbyacusis | 33.30% |
| Pressure Sores | 79.00% |
| Primary Biliary Cirrhosis (PBC) | 52.80% |
| Primary Cancer – Site Not Known | 95.10% |
| Primary Generalised Osteoarthritis | 74.00% |
| Prostate – Cancer Of | 75.80% |
| Prostatic Disease | 30.10% |
| Protozoal Diseases – Other / Type Not Known | 70.00% |
| Pseudogout | 69.60% |
| Psoriasis | 35.90% |
| Psychiatric Disorders Of Childhood – Other / Type Not Known | 66.70% |
| Psychotic Disorders – Other / Type Not Known | 68.10% |
| Ptosis | 34.30% |
| Pulmonary Embolus | 52.90% |
| Pulmonary Fibrosis – Other / Type Not Known | 81.80% |
| Pulmonary Valve Disease | 64.30% |
| Quadrantanopia | 64.00% |
| Raynaud’s Disease/Phenomenon | 41.60% |
| Rectal Prolapse | 35.30% |
| Rectum/Anus – Other Diseases Of / Type Not Known | 33.00% |
| Refractive Errors – Other / Type Not Known | 59.30% |
| Renal Calculi | 43.00% |
| Renal Failure – Acute | 68.70% |
| Renal Failure – Chronic | 71.10% |
| Renal Transplantation | 51.70% |
| Respiratory Tract – Other Cancers Of / Type Not Known | 84.80% |
| Retina And Optic Nerve – Other Diseases Of / Type Not Known | 76.80% |
| Retinal Artery Occlusion | 53.50% |
| Retinal Detachment | 63.20% |
| Retinal Vein Occlusion | 53.20% |
| Retinitis Pigmentosa | 87.20% |
| Retinopathy – Other / Type Not Known | 78.10% |
| Retts Disorder | 90.60% |
| Rheumatoid Arthritis | 74.70% |
| Rickets | 73.30% |
| Rosacea | 25.60% |
| Rotator Cuff Disorder | 42.10% |
| Sarcoidosis | 59.10% |
| Sarcomas – Other / Type Not Known | 87.20% |
| Schizoaffective Disorder | 71.50% |
| Schizophrenia | 69.70% |
| Schuermann’s Disease | 65.90% |
| Scleritis | 32.70% |
| Scoliosis | 61.30% |
| Scotoma | 53.80% |
| Seizures – Unclassified | 54.10% |
| Sensorineural Hearing Loss – Other Causes Of / Type Not Known | 43.90% |
| Sensorineural Hearing Loss Due To Trauma | 48.20% |
| Shoulder Disorders – Other / Type Not Known | 38.50% |
| Shoulder Instability | 43.50% |
| Silicosis | 52.40% |
| Sjogren’s Syndrome | 56.10% |
| Skin Cancers – Other / Type Not Known | 76.10% |
| Skin Disease – Other / Type Not Known | 38.80% |
| Sleep Apnoea – Obstructive | 28.80% |
| Slipped Upper Femoral Epiphysis | 68.40% |
| Small Bowel – Other Diseases Of / Type Not Known | 35.00% |
| Somatoform Disorders – Other / Type Not Known | 65.70% |
| Specific Learning Disorder – Other / Type Not Known | 67.50% |
| Speech Or Language Disorder | 58.40% |
| Spina Bifida | 85.40% |
| Spinal Cord Compression – Other Causes Of / Cause Not Known | 84.60% |
| Spinal Stenosis | 79.90% |
| Spine – Injuries/Fracture/Dislocation Of | 75.10% |
| Spondylolisthesis | 75.70% |
| Steatohepatitis – Non-Alcoholic (NASH) | 50.90% |
| Stokes Adams Attacks (Cardiovascular Syncope) | 71.90% |
| Stomach – Cancer Of | 91.30% |
| Strabismus (Squint) | 35.50% |
| Stress Reaction Disorders – Other / Type Not Known | 35.70% |
| Sudek’s Atrophy | 85.90% |
| Syncope – Other / Type Not Known | 51.30% |
| Syringomyelia / Syringobulbia | 80.50% |
| Systemic Lupus Erythematosus (SLE) | 62.80% |
| Systemic Sclerosis (Scleroderma) | 71.80% |
| Tachycardia | 40.80% |
| Temporal (Giant Cell) Arteritis (Headache) | 57.80% |
| Tendon Lesions | 40.90% |
| Tennis Elbow (Lateral Epicondylitis) | 33.10% |
| Tenosynovitis | 46.70% |
| Testicle – Cancer Of | 65.00% |
| Tetraplegia (Traumatic) | 99.10% |
| Thalassaemia | 46.20% |
| Thorax – Injury/Fracture/Dislocation Of | 47.80% |
| Thyroid Diseases – Other / Type Not Known | 35.60% |
| Torticollis | 56.20% |
| Tourette’s Syndrome | 48.60% |
| Tracheo-Oesophageal Fistula/Atresia | 53.40% |
| Transient Ischaemic Attacks (Tias) | 51.00% |
| Transplant Rejection – Renal | 74.30% |
| Tricuspid Valve Disease | 43.40% |
| Tuberculosis | 57.30% |
| Tumours – Benign – Other / Type Not Known | 58.90% |
| Tumours Of Bone – Benign | 64.90% |
| Tumours Of The Gastrointestinal Tract – Benign | 52.40% |
| Tunnel Vision | 63.60% |
| Ulcerative Colitis | 23.20% |
| Upper Limb – Injury/Fracture/Dislocation Of | 45.40% |
| Upper Respiratory Tract – Other Diseases Of / Type Not Known | 54.90% |
| Urinary Overflow | 21.10% |
| Urinary Tract Infection | 32.10% |
| Urticaria | 24.10% |
| Uterine Prolapse | 31.40% |
| Vasculitis – Other / Type Not Known | 65.50% |
| Venous Insufficiency – Chronic | 61.90% |
| Ventriculoseptal Defect (VSD) | 53.40% |
| Viral Diseases Excluding Hepatitis And Poliomyelitis -Other / Type Not Known | 61.00% |
| Vision – Other Diseases Affecting / Type Not Known | 70.50% |
| Visual Field Defects – Other / Type Not Known | 70.70% |
| Vitreous Disease – Other / Type Not Known | 71.50% |
| Vitreous Haemorrhage | 65.40% |
| Von Willebrand’s Disease | 43.00% |
| Whiplash Injury | 42.90% |
| Wilms Tumour | 55.20% |
| Wilson’s Disease | 68.30% |
| Wrist And Hand Disorders – Other / Type Not Known | 42.10% |
| Writer’s Cramp | 29.40% |
Success rates for PIP claims by condition
Does PIP get backdated 2022?
How to claim PIP – Claiming Personal Independence Payment can take up to four months after making your claim to you receiving any money. PIP cannot be backdated but your payments start from the date you made your claim to cover the handling time at the Department of Work and Pensions (DWP).
How long does it take for PIP to answer the phone?
Call waiting times for March 2023 – Mr Pursglove shared the latest average call waiting times for:
PIP – 37 minutes (37:01) DLA – 33 minutes (33:36) Attendance Allowance – 2 minutes (02:11) DLA65+ – 6 minutes (06:22)
The DWP Minister said: “There are no current targets for the Average Speed of Answer (ASA) for calls to the PIP, DLA and AA telephone enquiry lines. “The average speed of answering calls within AA and DLA65+ is within acceptable levels.”
